Comment on “The Importance of Structured Expert Elicitation to Inform Outcomes Following Treatment Discontinuation: Evidence Assessment Group Perspective

Dyfrig Hughes

doi:10.1007/s40273-026-01605-4

Comment on “The Importance of Structured Expert Elicitation to Inform Outcomes Following Treatment Discontinuation: Evidence Assessment Group Perspective

Dyfrig Hughes

North Wales Medical School

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	PharmacoEconomics
DOIs	https://doi.org/10.1007/s40273-026-01605-4
Publication status	Published - 5 Mar 2026

Access to Document

10.1007/s40273-026-01605-4

Embargoed Document

leniolisib letter
Accepted author manuscript, 93.9 KB
Embargo ends: 5/03/27

Cite this

@article{f088188c7da94cbe95f09b5bc646f118,

title = "Comment on “The Importance of Structured Expert Elicitation to Inform Outcomes Following Treatment Discontinuation: Evidence Assessment Group Perspective",

author = "Dyfrig Hughes",

year = "2026",

month = mar,

day = "5",

doi = "10.1007/s40273-026-01605-4",

language = "English",

journal = "PharmacoEconomics",

issn = "1170-7690",

publisher = "Adis",

}